by Vora Corporate Finance | Feb 19, 2021 | Articles, Capital Market Updates
Indian Economy performed above market expectations in Q3 at GDP growth rate of 0.1%. Optimism in markets have also continued in light of Covid vaccines. IPOs of Mrs. Bectors Food Specialities Limited and Burger King India Limited came in the month of December and were...
by Vora Corporate Finance | Jan 27, 2021 | Financial Advisory, Insights, Private Equity & IPO
Transaction: Zomato has raised $660 million in an investment round at the valuation of $3.9 billion. Tiger Global Management, Baillie Gifford, Luxor Capital, Kora Capital, Steadview, D1 Capital and Mirae Asset were the investors who participated in this round. On top...
by Vora Corporate Finance | Jan 27, 2021 | Financial Advisory, Insights
BSE Sensex went up by 8.46% in December 2020 to close at 47,751. Nifty 50 closed at 13,982, higher by 7.81% from 12,969 in November closing. Expectation of quick arrival of Covid-19 vaccines, slowing of Covid19 infections, abundant liquidity and expectation of...
by Vora Corporate Finance | Jan 25, 2021 | Insights
Indian Economy is pulling out of Covid-19’s impact and recovering at a pace that beats most predictions as per RBI Report. Estimated GDP growth in Q3 is likely to be positive 0.1%. The manufacturing and services purchasing managers’ index (PMI) at 56.3 and 53.7...
by Vora Corporate Finance | Jan 18, 2021 | Insights, Private Equity & IPO
Hyderabad based Gland Pharma Ltd. is an injectable-focused company with a footprint in 60 countries. Company mainly operates in complex injectable under B2B model. The issue price of the stock was kept Rs. 1490 to Rs. 1500 per share at P/E of around 30. IPO was...
